research use only
Camonsertib (RP-3500) is a highly potent and selective inhibitor of ATR kinase with an IC50 of 1 nM.
| Related Targets | ATM ATR | Click to Expand |
|---|---|---|
| Related Products | KU-55933 VE-821 KU-60019 Berzosertib (VE-822) Ceralasertib (AZD6738) AZ20 AZD0156 Mirin AZD1390 CP-466722 Elimusertib (BAY-1895344) hydrochloride ETP-46464 Elimusertib (BAY-1895344) CGK 733 VX-803 (M4344) AZ31 AZ32 HAMNO | Click to Expand |
| Related Compound Libraries | FDA-approved Drug Library Natural Product Library Apoptosis Compound Library DNA Damage/DNA Repair compound Library Cell Cycle compound library | Click to Expand |
| Targets |
|
|---|
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05566574 | Recruiting | Solid Tumor|Metastatic Cancer |
Memorial Sloan Kettering Cancer Center|Repare Therapeutics |
September 30 2022 | Phase 1|Phase 2 |
| NCT04972110 | Recruiting | Advanced Solid Tumor Adult |
Repare Therapeutics|Roche Pharma AG |
July 21 2021 | Phase 1|Phase 2 |
| NCT04855656 | Recruiting | Advanced Solid Tumor |
Repare Therapeutics|Debiopharm International SA |
April 30 2021 | Phase 1 |
| NCT02723864 | Completed | Neoplasms |
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) |
August 9 2017 | Phase 1 |
References |
|
| Molecular Weight | 410.47 | Formula | C21H26N6O3 |
| CAS No. | 2417489-10-0 | SDF | -- |
| Storage (From the date of receipt) | 3 years -20°C powder | ||
|
In vitro |
DMSO : 83 mg/mL ( (202.2 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.) Ethanol : 83 mg/mL Water : Insoluble |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
|||||
Molarity Calculator
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
* Indicates a Required Field